Validation of the Reflux Disease Questionnaire (RDQ) and Gastrointestinal Impact Scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population;Validación del Cuestionario sobre Alteraciones de Reflujo (RDQ) y de la Escala de Impacto de la Enfermedad por Reflujo Gastroesofágico (GIS) para población española

Gastroenterologia y Hepatologia

Volumn 32, Issue 4, 2009, Pages 264-273

  Nuevo, Javier ^a   Tafalla, Mónica ^a   Zapardiel, Javier ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Gastroesophageal reflux disease; GIS; Impact; Questionnaire; RDQ; Scale; Symptom evaluation

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SPAIN; VALIDATION STUDY;

FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; SPAIN;

EID: 67349154113     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2008.12.004     Document Type: Article

References (30)

1. Heading R.C. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol 231 Suppl (1999) 3-8
2. Ponce J, Vegazo O, Beltrán B, Jiménez J, Zapardiel J, Calle D, et al. Iberge Study Group. Prevalence of gastro-oesophageal reflux disease in Spain and associated factors. Aliment Pharmacol Ther. 2006;23:175-84.
3. Díaz-Rubio M., Moreno-Elola-Olaso C., Rey E., Locke III G.R., and Rodríguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 19 (2004) 95-105
4. Revicki D.A., Wood M., Maton P.N., and Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104 (1998) 252-258
5. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol 96 Suppl 8 (2001) 57-61
6. Calleja J.L., Bixquert M., Maldonado J., and SINERGE Study Group. Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study. Dig Dis Sci 52 (2007) 2858-2865
7. Piqué J.M., Kulich K.R., Vegazo O., Jiménez J., Zapardiel J., Carlsson J., et al. Repercusión de la enfermedad en pacientes con reflujo gastroesofágico. Evidencia de un estudio metodológico reciente en España. Gastroenterol Hepatol 27 (2004) 300-306
8. Wahlqvist P., Reilly M.C., and Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther 24 (2006) 259-272
9. Rey E., Moreno Elola-Olaso C., Rodríguez Artalejo F., and Díaz-Rubio M. Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain. Rev Esp Enferm Dig 98 (2006) 518-526
10. Wahlqvist P., Karlsson M., Johnson D., Carlsson J., Bolge S.C., and Wallander M.A. Relationship between symptom load of gastroesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther 27 (2008) 960-970
11. Grupo de trabajo de la guía de práctica clínica sobre ERGE. Manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE). Guía de práctica clínica. Barcelona: Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano; 2001. Programa de Elaboración de Guías de Práctica Clínica en Enfermedades Digestivas, desde la Atención Primaria a la Especializada: 1.
12. Vaezi M.F. Atypical manifestations of gastroesophageal reflux disease. MedGenMed 7 (2005) 25
13. Jones R.H., Hungin A.P., Phillips J., and Mills J.G. Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1 (1995) 149-154
14. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 33 (1998) 1023-1029
15. Dent J., Brun J., Fendrick A.M., Fennerty M.B., Janssens J., Kahrilas P.J., et al. An evidence based appraisal of reflux disease management: the Genval Workshop Report. Gut 44 Suppl 2 (1999) 1-16
16. Jones R., Coyne K., and Wiklund I. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 25 (2007) 1451-1459
17. Shaw M.J., Talley N.J., Beebe T.J., Rockwood T., Carlsson R., Adlis S., et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 96 (2001) 52-57
18. Nocon M., Kulig M., Leodolter A., Malfertheiner P., and Willich S.N. Validation of the Reflux Disease Questionnaire for a German population. Eur J Gastroenterol Hepatol 17 (2005) 229-233
19. Dimenäs E., Glise H., Hallerbäck B., Hernqvist H., Svedlund J., and Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 30 (1995) 1046-1052
20. Dimenäs E., Carlsson G., Glise H., Israelsson B., and Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 221 Suppl (1996) 8-13
21. Kulich K.R., Piqué J.M., Vegazo O., Jiménez J., Zapardiel J., Carlsson J., et al. Validación psicométrica de la traducción al español de la escala de evaluación de síntomas gastrointestinales (GSRS) y del cuestionario de calidad de vida de reflujo y dispepsia (QOLRAD) en los pacientes con enfermedad por reflujo gastroesofágico. Rev Clin Esp 205 (2005) 588-594
22. Wiklund I.K., Junghard O., Grace E., Talley N.J., Kamm M., Veldhuyzen van Zanten S., et al. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg 583 Suppl (1998) 41-49
23. Lizán Tudela L., Reig Ferrer A., Richart Martínez M., and Cabrero García J. La evaluación de la calidad de vida relacionada con la salud mediante las láminas COOP/WONCA. Med Clin (Barc) 114 Supl 3 (2000) 76-80
24. Lizán Tudela L., and Reig Ferrer A. La evolución de la calidad de vida relacionada con la salud en la consulta: las viñetas COOP/WONCA. Aten Primaria 29 (2002) 378-384
25. Guyatt G.H., Juniper E.F., Walter S.D., Griffith L.E., and Goldstein R.S. Interpreting treatment effects in randomised trials. BMJ 316 (1998) 690-693
26. Revicki D.A., Sorensen S., Maton P.N., and Orlando R.C. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 16 (1998) 284-291
27. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47 (1994) 81-87
28. Kazis L.E., Anderson J.J., and Meenan R.F. Effect sizes for interpreting changes in health status. Med Care 27 (1989) 178S-189S
29. Bland J.M., and Altman D.G. Cronbach's alpha. BMJ 314 (1997) 572
30. Kulich K.R., Madisch A., Pacini F., Piqué J.M., Regula J., Van Rensburg C.J., et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes 6 (2008) 12